Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2 and the government funding status notice was removed; no study content or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:12:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide status notice about a lapse in government funding and the NIH Clinical Center’s operations, and updated the site version to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    New UI elements were added: a glossary toggle, a 'Last Update Submitted that Met QC Criteria' entry, a 'No FEAR Act Data' notice, and a revision tag showing v3.4.0. The prior items—'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4—were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:18:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland and Pennsylvania entries and updated the page revision to v3.3.3. Removed the Maryland Locations and Pennsylvania Locations sections and the HHS Vulnerability Disclosure link, replacing revision v3.3.2 with v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T12:32:30.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.2, replacing the previous v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:05.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.